Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells

Clin Immunol. 2008 May;127(2):130-7. doi: 10.1016/j.clim.2008.01.005. Epub 2008 Feb 15.

Abstract

The observation that bone marrow derived hematopoietic cells are potent inducers of tolerance has generated interest in trying to establish transplantation tolerance by inducing a state of hematopoietic chimerism through allogeneic bone marrow transplantation. However, this approach is associated with serious complications that limit its utility for tolerance induction. Here we describe the development of a novel approach that allows for tolerance induction without the need for an allogeneic bone marrow transplant by combining non-myeloablative host conditioning with delivery of donor alloantigen by adoptively transferred T cells. CBA/Ca mice were administered 2.5 Gy whole body irradiation (WBI). The following day the mice received K(b) disparate T cells from MHC class I transgenic CBK donor mice, as well as rapamycin on days 0-13 and anti-CD40L monoclonal antibody on days 0-5, 8, 11 and 14 relative to T cell transfer. Mice treated using this approach were rendered specifically tolerant to CBK skin allografts through a mechanism involving central and peripheral deletion of alloreactive T cells. These data suggest robust tolerance can be established without the need for bone marrow transplantation using clinically relevant non-myeloablative conditioning combined with antigen delivery by T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer / methods
  • Animals
  • Chimerism
  • Female
  • Graft Survival / immunology
  • Immunosuppressive Agents / pharmacology*
  • Isoantigens / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred CBA
  • Mice, Transgenic
  • Sirolimus / pharmacology*
  • Skin Transplantation / immunology*
  • T-Lymphocytes / immunology*
  • Transplantation Tolerance / immunology*
  • Whole-Body Irradiation

Substances

  • Immunosuppressive Agents
  • Isoantigens
  • Sirolimus